Imagin Medical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMEXF research report →
About the company
Imagin Medical Inc. , a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device.
- CEO
- E. James Hutchens
- IPO
- 2009
- Employees
- 10
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $1.08K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -3.94
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 20.04%
- ROIC
- -2823.42%
- Revenue
- $0 · 0.00%
- Net Income
- $-2,492,000 · 78.28%
- EPS
- $-0.25 · 80.31%
- Op Income
- $-3,402,000
- FCF YoY
- 16.90%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.72
- Avg Volume
- 19.03K
Get TickerSpark's AI analysis on IMEXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IMEXF coverage
Recent articles, reports, and earnings notes.
No research on IMEXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMEXF report →Similar companies
Peers in the same neighborhood.